References
- Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota-introducing the concept of prebi-otics. J Nutr 1995; 125: 1401–12.
- Tomomatsu H. Health effects of oligosaccharides. Food Technology 1994; 48: 61–5.
- Gibson GR, Collins, MD. Concept of balanced colonic mi-crobiota, prebiotics, and synbiotics. In: Hanson, LA, Yolken, RH, eds. Probiotics, other Nutritional Factors, and Intestinal Microflora. Nestle Nutrition Services, Philadelphia, Lippin-cott-Raven, 1999: 139–156.
- Playne, MJ, Crittenden, RG. Commercially available oligosaccharides. In: Bulletin of the IDF no. 313, Brussels, 1996: 10–22.
- Matsumoto, K, Kobayashi, Y, Ueyama, S, Watanabe, T, Tanaka, R, Kan, T., Kuroda, A, Sumihara, Y. Galac- tooligosaccharides In: Nakakuki, T. ed. Oligosaccharides. Production, properties and applications. Japanese Technology Reviews, Vol. 3, no. 2, Gordon and Breach Science Publish-ers, Switzerland, Australia, 1993: 90–106.
- Crittenden, RG. Prebiotics. In: Tannock, GW, ed. Probi-otics-a Critical Review. Norfolk, UK, Horizon Scientific Press, 1999: 141–156.
- Ziemer CJ, Gibson GR. An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int Dairy J 1998; 8: 473–9.
- DeMan JD, Rogosa M, Sharpe ME. A medium for the cultivation of lactobacilli. J Appl Bacteriol 1960; 23: 130–5.
- Scardovi, V. Genus Bifidobacterium. In: Bergey's Manual of Systematic Bacteriology Vol 2, Sneath, P, Mair, N, Sharpe, E, Holt, JG, eds. New York, Williams and Wilkins, 1986: 1418–1434.
- Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofruc-tose and inulin. Gasteroenterology 1995; 108: 975–82.
- Yamazaki H, Dilawri N. Measurement of growth of bifidobacteria on inulofructosaccharides. Lett Appl Microbiol 1990; 10: 229–32.
- Tanaka, R, Matsumoto, K. Recent progress on prebiotics in Japan, including galacto-oligosaccharides. In: Bulletin of the IDF no. 336, Brussels, 1998: 21–27.
- Sghir A, Chow JM, Mackie RI. Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosacchride as selective substrate. J Appl Mi-crobiol 1998; 85: 769–77.
- Bouhnik, Y, Flourié, B, D'Agay-Abensour, Pochart, P, Gramet, G, Durand, M, Rambaud, J-C. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997; 127: 444–448.
- Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructooligosacchrides on intestinal flora and human health. Bifidobacteria Microflora 1986; 5: 37–50.
- Hartemink R, Quataert MCJ, van Laare KMJ, Nout MJR, Rombouts FM. Degradation and fermentation of fructo-oligosaccharides by oral streptococci. J Appl Bacteriol 1995; 79: 551–7.
- Hartemink R, van Laere KMJ, Rombouts FM. Growth of enterobacteria on fructo-oligosacharides. J Appl Microbiol 1997; 83: 367–74.
- Alles MS, Hautvast JGA, Nagengast FM, Hartemink R, van Laere KMJ, Jansen JBM. Fate of fructo-oligosaccharides in the human intestine. Brit J Nutr 1996; 76: 211–21.
- Ito M, Deguchi Y, Miyamori A, Matsumoto K, Kikuchi H, Kobayashi Y, Yajima T, Kann T. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990; 3: 285–92.
- Terada A, Hara H, Mitsuoka T. Effect of dietary alginate on the faecal microbiota and faecal metabolic activity in humans. Microb Ecol Health Dis 1995; 8: 259–66.
- Modler WH. Bifidogenic factors—sources, metabolism and applications. Int Dairy J 1994; 4: 383–407.
- Salminen, S, Salminen, E. Lactulose lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gas-troenterol 1997; 32 Suppl 222: 45–48.